• SENSEX 78,094.64
    166.49 (+0.21%)
  • BANKNIFTY 57,264.85
    117.35 (+0.21%)
  • Bajaj Finance
    1,151.20 1,151.20(%)
  • Torrent Pharma.
    5,139.30 5,139.30(%)
  • Netweb Technol.
    4,597.95 5,241.65(%)
  • TVS Motor Co.
    4,320.00 4,320.00(%)
  • Rossell Techsys
    979.95 1,111.00(%)
  • Indo-MIM
    815.90 815.90(%)
  • Kaynes Tech
    3,860.55 7,705.00(%)
  • Hero Motocorp
    5,397.80 6,390.00(%)
  • 63 Moons Tech.
    949.65 1,029.35(%)
  • Adani Ports
    1,707.00 1,891.80(%)
  • Shadowfax Technologies
    253.35 253.35(%)
  • Kalyan Jewellers
    610.15 327.15(%)
  • M & M
    3,456.00 3,840.00(%)
  • Tata Motors
    440.40 508.95(%)
  • HFCL
    194.30 229.40(%)
  • Hyundai Motor I
    2,208.90 2,889.65(%)
  • Swiggy
    280.00 235.85(%)
  • TBO Tek
    1,565.80 1,764.00(%)
  • Reliance Industries
    1,309.30 1,611.20(%)
  • Eicher Motors
    7,795.00 5,390.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bharat Immunological & Biological Corporation Ltd Pharmaceuticals - Indian - Formulations

  • Govt of India
  • BSE Code : 4148.0
  • ISIN : INE994B01014
15.40 0 (0.13%)
  • As on 01 Aug 2026 (EOD)

  • Today’s Low

    15.25

  • Today’s High

    15.55

  • Open

    15.25

  • Perv Close

    15.38

  • 52W Low

    14.10

  • 52W High

    23.19

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    66.50

  • Div & Yield %

    0.00

  • Book Value(₹)

    -7.54

  • Debt-Equity Ratio

    0.13

  • AGM Date

    31-Jul-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    66.50

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    43.18

  • BV (₹)

    -7.50

  • Sales( ₹ in Cr.)

    44.61

  • NP (in Cr.)

    -17.06

  • NP Var(%)

    -95.0

  • Div%

    0.0

  • CPS (₹)

    -3.90

  • EPS (₹)

    -4.00

  • Traded Value (₹ in Lakhs)

    86.49

  • 52 Week High

    23.19

  • 52 Week Low

    14.10

  • Price BSE

    20.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    86.49

  • P/C Ratio

    -5.10

  • P/E Ratio

    -5.10

  • Price Vs.BV

    -4.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar
INCOME :            
Sales Turnover 44.61 78.39 85.33 66.84 83.65 34.80
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 44.61 78.39 85.33 66.84 83.65 34.80
Other Income 2.80 1.10 1.68 1.18 4.22 1.39
Stock Adjustments -5.95 -0.44 -20.15 12.99 13.55 0.00
Total Income 41.46 79.05 66.86 81.01 101.42 36.19
EXPENDITURE :            
Raw Materials 35.71 64.93 67.74 74.30 92.79 26.97
Power and Fuel Cost 1.35 1.69 1.55 1.85 1.74 1.24
Employee Cost 15.32 13.85 14.44 11.37 9.78 10.31
Other Manufacturing Expenses 1.16 1.39 1.22 1.53 1.17 3.23
Selling and Administration Expenses 1.05 0.73 0.60 0.65 0.45 0.96
Miscellaneous Expenses 2.53 0.33 0.49 0.53 0.59 0.02
Employee Benefit Expenses 15.32 13.85 14.44 11.37 9.78 10.31
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 57.12 82.92 86.05 90.22 106.52 42.72
Operating Profit -15.66 -3.87 -19.18 -9.22 -5.10 -6.54
Interest 7.05 5.60 4.79 4.75 2.00 1.01
Gross Profit -22.71 -9.47 -23.97 -13.97 -7.10 -7.55
Depreciation 0.15 0.21 0.24 0.24 0.28 0.41
Profit Before Tax -22.86 -9.68 -24.21 -14.21 -7.38 -7.96
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -5.79 -0.93 -6.10 -3.99 -1.58 -3.70
Reported Net Profit -17.06 -8.75 -18.11 -10.21 -5.79 -4.26
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -17.06 -8.75 -18.11 -10.21 -5.79 -4.26
Adjustment below Net Profit 0.00 0.00 0.00 0.01 -1.02 0.01
P & L Balance brought forward -49.57 -40.82 -22.71 -12.50 -5.69 -1.43
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -66.63 -49.57 -40.82 -22.71 -12.50 -5.69
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -3.95 -2.03 -4.19 -2.36 -1.34 0.00
Earnings Per Share(Adj)-Unit Curr -3.95 -2.03 -4.19 -2.36 -1.34 0.00
Book Value -5.43 -1.48 0.55 4.74 7.10 8.68
Book Value(Adj)-Unit Curr -5.43 -1.48 0.55 4.74 7.10 8.68

Shareholding Pattern

  • Promoter Group

    59.25%

  • Public Share Holding

    40.75%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 25,585,993 59.25 25,585,993 1
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7 0.00 0 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 25,586,000 59.25 25,585,993 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 299,537 0.69 245,637 102
Clearing Members 29,442 0.07 29,442 13
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 222,042 0.51 222,042 160
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,129,698 7.25 3,129,698 62
Individuals holding nominal share capital up to Rs. 1 lakh 13,913,280 32.22 13,023,830 34,967
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1 0.00 1 1
Others 0 0.00 0 0
Sub Total 17,594,000 40.75 16,650,650 35,305
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 43,180,000 100.00 42,236,643 35,313

Company Background

Bharat Immunological & Biological Corporation LtdPharmaceuticals - Indian - Formulations

  • Bharat Immunological & Biological Corporation Ltd
  • BSE Code : 4148.0
  • ISIN : INE994B01014

  • Incorporation Year

    1989

  • Registered Office

    BIBCOL OPV Plant Village Chola
    , Bulandshahr,
    Uttar Pradesh-203203

  • Telephone

    91-5732-238210

  • FAX

  • Chairman

    Y K Gupta

  • Managing Director

    Sanjay Kumar Mishra

  • Company Secretary

    Sandip K Lal

  • Auditor

    Reshma & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Mas Services Limited
    T-34 2nd Floor,
    Okhla Industrial Are,Phase II
    Mumbai - New Delhi - 110020

Bharat Immunological & Biological Corporation Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bharat Immunolog 15.40 47.41 44.61 -3.68 0.00
Abbott India 27,784.15 7,217.19 6,929.05 38.04 43.78
Astrazeneca Phar 8,103.65 2,304.07 2,275.58 108.03 27.86
P & G Health Ltd 6,597.45 944.52 934.17 33.50 71.75
Glaxosmi. Pharma 2,653.45 3,932.76 3,790.20 44.42 58.17
Cipla 1,472.95 20,102.60 18,979.95 38.71 13.88
Amrutanjan Healt 515.00 469.50 451.82 25.71 21.89
Fermenta Biotec. 501.25 474.15 450.25 22.95 18.77
Bliss GVS Pharma 467.40 773.53 729.81 51.25 12.51
Guj. Themis Bio. 358.85 152.47 150.80 83.84 27.21
Ambalal Sarabhai 34.87 19.52 3.94 24.38 6.77